BioHealth News Archive
Emergent BioSolutions Signs Development and Manufacturing Agreement With Novavax for Experimental Vaccine Candidate for Coronavirus Disease | Emergent BioSolutions Inc.
GAITHERSBURG, Md., March 10, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered into an agreement with Novavax, Inc.…
Read MoreNEA Closes On $3.6B for New Fund with Focus on Early-Stage Technology and Healthcare Investments
MENLO PARK, Calif. and NEW YORK, March 11, 2020 /PRNewswire/ -- New Enterprise Associates, Inc. (NEA) today announced that it has closed on $3.6…
Read MoreUniform nanoparticle vaccines
Precise loading of diverse peptides for vaccination is enabled by a strategy for peptide–TLR7/8 conjugate self-assembly of uniform nanoparticles. The approach is compatible with…
Read MoreFDA and FTC Send Joint Warning Letters to Seven Companies for “Selling Fraudulent COVID-19 Products” | Wilson Sonsini Goodrich & Rosati – JDSupra
The number of cases of SARS-CoV-2 coronavirus infection, and COVID-19, the disease caused by the virus, continue to increase in the United States—both in…
Read MoreUniversity of Maryland athletics announces spectator restrictions amid coronavirus outbreak – Baltimore Sun
University of Maryland athletics on Wednesday announced a series of safety measures for its home events amid concern over the coronavirus outbreak, now labeled…
Read MoreNew Enterprise Associates Amasses $3.6 Billion for 17th Fund – WSJ
New Enterprise Associates has raised $3.6 billion for its 17th venture fund, the largest in the more than 42-year history of the firm. NEA…
Read MoreTop 15 Best-Selling Drugs of 2019
GEN publishes its updated annual A-List highlighting the top 15 best-selling drugs of 2019. Eleven of last year’s 15 top-selling drugs registered year-over-year sales…
Read MoreAll you need to know about TBS Osteo – Medimaps
All TBS Osteo features and main arguments. Included, in greater detail. What is TBS Osteo powered by TBS iNsight and what is TBS (Trabecular…
Read MoreEmergent Biosolutions, Inc. (NYSE:EBS), Novavax, Inc. (NASDAQ:NVAX) – Emergent BioSolutions CEO Talks Coronavirus Vaccine Development | Benzinga
Global life sciences company Emergent Biosolutions Inc EBS 6.61% CEO Bob Kramer said Thursday that his company's partnership with Novavax, Inc. NVAX 6.3% could…
Read MoreFDA Clears First Clinical Study for a Polymicrobial Phage Library-Based Treatment for Antibiotic-Resistant Infections | Business Wire
GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant…
Read MoreBaltimore health tech startup b. well Connect Health raises $16M – Baltimore Business Journal
Baltimore health tech startup b. well Connected Health has raised a $16 million round as it looks to accelerate its growth. The Series A…
Read MoreNIST Director Testifies Before House Science Subcommittee on Agency Reauthorization; Touts Success of the Manufacturing USA Program in Promoting Technology Transfer – ASME
Last Wednesday, the House Science Committee, Subcommittee on Research and Technology, invited Under Secretary of Commerce and Director of the National Institute of Standards…
Read MoreJohns Hopkins microbiologists develop coronavirus screening test
BALTIMORE — Two Johns Hopkins microbiologists have developed an in-house coronavirus screening test that may soon allow the health system to test as many…
Read MoreRoche gets special FDA nod for Covid-19 diagnostic test – MedCity News
The Food and Drug Administration has given an emergency approval to a test made by Swiss drug and diagnostics maker Roche for detecting the…
Read MoreQIAGEN Gains BARDA Funding for Approval Process of QIAstat-Dx Test Kit for SARS-CoV-2 Coronavirus
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will develop a new QIAstat-Dx test kit to differentiate the novel SARS-CoV-2 coronavirus from…
Read More